Loading publications…
The last 5 uploaded publications
Lysosomal membrane permeabilization enhances the anticancer effects of RNA Polymerase I transcription inhibitors
Lucille Ferret, Jonathan Pol, Allan Sauvat, Gautier Stoll, Karla Alvarez-Valadez, Alexandra Müller, Julie Le Naour, F. Peyre, Gerasimos Anagnostopoulos, Isabel Martins, Maria Chiara Maiuri, Harald Wodrich, Lionel Guittat, Jean‐Louis Mergny, Guido Guido Kroemer, Mojgan Djavaheri‐Mergny (2025). Lysosomal membrane permeabilization enhances the anticancer effects of RNA Polymerase I transcription inhibitors. , DOI: https://doi.org/10.1101/2025.03.03.641132.
Preprint72 days agoA protocol for measuring phenotypical facial disease markers in a mouse model of iatrogenic Cushing’s syndrome
Hui Pan, Ai-Ling Tian, Isabel Martins, Guido Guido Kroemer, Oliver Kepp (2025). A protocol for measuring phenotypical facial disease markers in a mouse model of iatrogenic Cushing’s syndromeDOI: https://doi.org/10.1016/bs.mcb.2025.02.007,
Chapter in a book72 days agoMethods for experimentally increasing circulating acyl-CoA-binding protein (ACBP) levels in mice under chronic restraint stress
Hui Chen, Yanbing Dong, Rong Yan, Flavia Lambertucci, Sijing Li, Guido Guido Kroemer, Isabel Martins (2025). Methods for experimentally increasing circulating acyl-CoA-binding protein (ACBP) levels in mice under chronic restraint stressDOI: https://doi.org/10.1016/bs.mcb.2025.04.002,
Chapter in a book72 days agoAcyl CoA binding protein (ACBP): an autophagy checkpoint that can be targeted for improving cancer immunosurveillance
Léa Montégut, Isabel Martins, Guido Guido Kroemer (2024). Acyl CoA binding protein (ACBP): an autophagy checkpoint that can be targeted for improving cancer immunosurveillance. , 13(1), DOI: https://doi.org/10.1080/2162402x.2024.2413200.
Article72 days agoBenzodiazepines compromise the outcome of cancer immunotherapy
Léa Montégut, Lisa Derosa, Meriem Messaoudene, Hui Chen, Flavia Lambertucci, Bertrand Routy, Laurence Zitvogel, Isabel Martins, Guido Guido Kroemer (2024). Benzodiazepines compromise the outcome of cancer immunotherapy. , 13(1), DOI: https://doi.org/10.1080/2162402x.2024.2413719.
Article72 days ago